Tags |
|
|
Links |
|
|
Actual - Malpractice And Politics
In this article we're going to look at the ugly political side of malpractice which is most likely the main reason that malpractice laws are not to
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ughened.
This article is focusing mainly on the problem that they are having in PA in the good old United States, the worst country for malpractic
This article is focusing mainly on the problem that they are having in PA in the good old United States, the worst country for malpractic
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
suits in the whole world.
Pennsylvania is in the midst of a terrible health crisis, including medical malpractice which is at the top of the list
Pennsylvania is in the midst of a terrible health crisis, including medical malpractice which is at the top of the list
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
. The legislature is constantly debating remedies to the problem but nobody is coming up with a solution. The main problem is that there isn't en
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ugh data to determine if a cap should be put on malpractice claims, the amount of money one can get from a claim. Plus they're not even sure if pu
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
tting on this cap is going to lower insurance premiums or not as that is out of their control.
The most recent proposal was to put a $250,000 cap
The most recent proposal was to put a $250,000 cap
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
n any malpractice claim for what they term "pain and suffering." Because medical malpractice premiums are so high in this state it is believed tha
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
t is the reason why so few new doctors are setting up shop in PA and why others are actually leaving the state. There are actually documented case
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
of premiums going up from $20,000 to $60,000 to cover malpractice insurance in just one year and that's for people who have never been sued.
Sam
Sam
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
Marshall, a lobbyist representing the Insurance Federation of Pennsylvania, predicted that malpractice premiums would go down by about 20 percent i
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
caps were put in place on malpractice suits. But there is no real evidence to support this claim, not with premiums going up for doctors who have
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
never been sued.
The opposite end of the argument insists that medical malpractice premiums wouldn't go down by more than one half of one percent,
The opposite end of the argument insists that medical malpractice premiums wouldn't go down by more than one half of one percent,
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
according to Howard P. Weiss, a former insurance executive. He said since very few pain and suffering awards even come close to $250,000 the cap
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
would have little to no effect on those claims.
The main problem though seems to be between republicans and democrats in congress. The trial lawy
The main problem though seems to be between republicans and democrats in congress. The trial lawy
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ers are the republican's enemies. The republicans want to embarrass them because they support the democrats. The democrats, on the other hand, wa
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
t to stick it to the doctors who mostly give their money to the republicans. So in English, the democrats who are against the doctors want to see
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
them pay, thus have no desire to see a cap on pain and suffering cases. As far as they are concerned, malpractice premiums can go through the roof
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
The republicans, of course, take the opposite stance. This back and forth, in the meantime, basically brings all progress to a standstill becaus
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
e nobody can get any laws passed.
If the two parties would just put their partisan differences aside, something they are unable to do on many issu
If the two parties would just put their partisan differences aside, something they are unable to do on many issu
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s like social security and Medicare, then maybe a solution to this problem could be found.
At the rate the two parties are going, this is unlikely
At the rate the two parties are going, this is unlikely
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.actual.org.ua/article/130407/actual-Malpractice-And-Politics.html">Malpractice And Politics</a>
BB link (for phorums):
[url=http://www.actual.org.ua/article/130407/actual-Malpractice-And-Politics.html]Malpractice And Politics[/url]
Related Articles:
How to Find the Right Virtual Assistant for You
Everything You Need to Know About Secured Loans
Bookmark it:
|